Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target

Song, K.-A., Hosono, Y., Turner, C., Jacob, S., Lochmann, T. L., Murakami, Y., Patel, N. U., Ham, J., Hu, B., Powell, K. M., Coon, C. M., Windle, B. E., Oya, Y., Koblinski, J. E., Harada, H., Leverson, J. D., Souers, A. J., Hata, A. N., Boikos, S., Yatabe, Y., Ebi, H., Faber, A. C.
The American Association for Cancer Research (AACR)
Published 2018